- Home
- HOOK vs OMEX Comparison
HOOK vs OMEX Comparison
Compare HOOK & OMEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- OMEX
- Stock Information
- Founded
- HOOK 2011
- OMEX 1986
- Country
- HOOK United States
- OMEX United States
- Employees
- HOOK N/A
- OMEX N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- OMEX Marine Transportation
- Sector
- HOOK Health Care
- OMEX Consumer Discretionary
- Exchange
- HOOK Nasdaq
- OMEX Nasdaq
- Market Cap
- HOOK 9.3M
- OMEX 11.0M
- IPO Year
- HOOK 2019
- OMEX N/A
- Fundamental
- Price
- HOOK $1.25
- OMEX $1.19
- Analyst Decision
- HOOK Buy
- OMEX
- Analyst Count
- HOOK 4
- OMEX 0
- Target Price
- HOOK $10.67
- OMEX N/A
- AVG Volume (30 Days)
- HOOK 62.9K
- OMEX 2.7M
- Earning Date
- HOOK 08-07-2025
- OMEX 08-08-2025
- Dividend Yield
- HOOK N/A
- OMEX N/A
- EPS Growth
- HOOK N/A
- OMEX N/A
- EPS
- HOOK N/A
- OMEX 0.23
- Revenue
- HOOK $9,351,000.00
- OMEX $700,613.00
- Revenue This Year
- HOOK N/A
- OMEX N/A
- Revenue Next Year
- HOOK N/A
- OMEX N/A
- P/E Ratio
- HOOK N/A
- OMEX $5.71
- Revenue Growth
- HOOK N/A
- OMEX N/A
- 52 Week Low
- HOOK $0.72
- OMEX $0.27
- 52 Week High
- HOOK $6.77
- OMEX $5.46
- Technical
- Relative Strength Index (RSI)
- HOOK 38.94
- OMEX 60.91
- Support Level
- HOOK $1.23
- OMEX $1.19
- Resistance Level
- HOOK $1.30
- OMEX $1.43
- Average True Range (ATR)
- HOOK 0.06
- OMEX 0.17
- MACD
- HOOK -0.03
- OMEX 0.02
- Stochastic Oscillator
- HOOK 5.97
- OMEX 67.02
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.
About OMEX Odyssey Marine Exploration Inc.
Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodule (battery metals) projects. Its projects include ExO Phosphate project, CIC, Ocean Minerals, and LIHIR Gold project.